(Q34419639)

2 August 2017

1 reference

title

How should we make the admission decision in community-acquired pneumonia? (English)

1 reference

2 August 2017

1 reference

Aronsky D

1

1 reference

2 August 2017

Dean NC

series ordinal

2

1 reference

2 August 2017

publication date

1 November 2001

1 reference

Medical Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

85

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1397-1411

1 reference

Assessing the quality of clinical data in a computer-based record for calculating the pneumonia severity index

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

A prognostic rule for elderly patients admitted with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Implementation of admission decision support for community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Predicting death in patients hospitalized for community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

7 January 2021

Pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

A prediction rule to identify low-risk patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Automatic detection of acute bacterial pneumonia from chest X-ray reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Validation of the pneumonia severity index. Importance of study-specific recalibration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Unlocking clinical data from narrative reports: a study of natural language processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Severity prediction rules in community acquired pneumonia: a validation study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Patients hospitalized after initial outpatient treatment for community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Defining severe community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

The cost of treating community-acquired pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Toward electronic medical records that improve care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Clinical prediction rules. Applications and methodological standards

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

Will payment based on diagnosis-related groups control hospital costs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970387-4

10.1016/S0025-7125(05)70387-4

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference